<DOC>
	<DOCNO>NCT01206803</DOCNO>
	<brief_summary>The aim study explore ovarian response term oocyte number ovarian stimulation fix gonadotropin dose GnRH-antagonist protocol endocrine ( AMH , FSH ) , demographic ( age ) , sonographic ( antral follicle count ) genetic factor ( polymorphisms gonadotropin receptor secrete gonadotropin ) .</brief_summary>
	<brief_title>Ovarian Response Prediction In Vitro Fertilization ( IVF ) Patients</brief_title>
	<detailed_description>Assisted reproduction in-vitro fertilisation play pivotal role treatment infertility , understand reproductive biology , future population dynamic . The success assist reproductive technology ( ART ) critically dependent optimize protocol control ovarian stimulation aim provide adequate number good quality oocytes in-vitro laboratory procedure . Interindividual variation response follicle-stimulating hormone ( FSH ) widespread problem clinical economical implication . A group patient ( 9 % -24 % ) tend respond poorly control ovarian stimulation ( COS ) whereas patient tend overrespond ( 2.5 % ) thus run risk develop ovarian hyperstimulation syndrome , potentially life-threatening disease . Polymorphisms gonadotropin receptor seem influence outcome control ovarian hyperstimulation treatment , e.g . contribute variation ovarian response exogenous FSH individual . Other predictive factor include demographic ( age ) , sonographic ( follicular count ovary , ovarian volume ) , endocrine ( serum gonadotropin level Anti-Muellerian Hormone ) life-style factor ( smoking , obesity ) . Such factor routinely obtain prior treatment cycle , use determine optimal FSH start dose best treatment regimen . The identification gonadotropin receptor polymorphisms variant secrete gonadotropin prior ovarian stimulation treatment allow clinician tailor start dose rFSH , especially patient undergo first treatment cycle , ovarian response prediction prevent cycle cancellation due low high ovarian response reduce risk OHSS . The aim present study identify prevalence FSH LH receptor polymorphisms hormonal variant LH study variation attributable genetics factor control already establish predictor ovarian response exogenous FSH multi-variate analysis .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Female patient treat physician decides treatment long act FSH 150Âµg GnRHantagonist protocol indicate . Contraindications use gonadotropin ( e.g. , tumor , pregnancy/lactation , undiagnosed vaginal bleeding , hypersensitivity , ovarian cyst ) Use hormonal preparation within one month prior inclusion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ovarian stimulation</keyword>
	<keyword>recombinant FSH</keyword>
	<keyword>GnRH-antagonist</keyword>
	<keyword>corifollitropin alfa</keyword>
</DOC>